PetMed Express downgraded by Sidoti with a new price target
$PETS
Retail-Drug Stores and Proprietary Stores
Consumer Staples
Sidoti downgraded PetMed Express from Buy to Neutral and set a new price target of $39.00
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/25/2023 | $20.00 | Buy | Lake Street |
| 1/25/2022 | $25.00 → $21.00 | Underweight | Morgan Stanley |
| 1/20/2022 | $32.00 | Neutral → Buy | Sidoti |
| 11/18/2021 | $25.00 | Underweight | Morgan Stanley |
| 10/1/2021 | $28.00 | Hold | Jefferies |
| 8/5/2021 | $22.00 | Underperform | Credit Suisse |
DELRAY BEACH, Fla., Aug. 12, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (the "Company") dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced that its Chief Executive Officer, Sandra Campos, and Chief Financial Officer, Robyn D'Elia, have resigned from their positions and employment with the Company. As part of the leadership changes, Leslie C.G. Campbell, the Chair of the Company's Board of Directors (the "Board"), has assumed the role of Interim Chief Executive Officer, and Douglas Krulik, the Company's Chief Accounting Officer, has assumed the role of Interim Principal Financial Officer. The Company has initiated a search for a new Chief Executive Officer and Chi
DELRAY BEACH, Fla., July 23, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. ("PetMeds®") (NASDAQ:PETS) today announced that it partnered with the myBalto Foundation for its recent "Top of the Class" fundraising drive, resulting in nearly $45,000 in donations. myBalto is a leading platform dedicated to empowering veterinary hospitals to support pets with critical veterinary care. Its Foundation offers veterinary hospitals a free Angel Fund, eliminating the administrative burdens of setting up and managing a traditional charity, to help pet parents in need pay for emergency veterinarian costs. "PetMeds is proud to stand alongside organizations like myBalto Foundation that are expanding acces
DELRAY BEACH, Fla., July 03, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. ("PetMeds®") (NASDAQ:PETS) received on July 2, 2025, an expected notice (the "Notice") from The Nasdaq Stock Market LLC ("Nasdaq") indicating that, as a result of not having timely filed its Annual Report on Form 10-K for the fiscal year ended March 31, 2025 (the "Form 10-K"), with the Securities and Exchange Commission ("SEC"), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Listing Rule"), which requires timely filing of all required periodic financial reports with the SEC. The Notice has no immediate effect on the listing or trading of the Company's common stock on Nasdaq. The Notice
4 - PETMED EXPRESS INC (0001040130) (Issuer)
4 - PETMED EXPRESS INC (0001040130) (Issuer)
4 - PETMED EXPRESS INC (0001040130) (Issuer)
8-K - PETMED EXPRESS INC (0001040130) (Filer)
NT 10-Q - PETMED EXPRESS INC (0001040130) (Filer)
8-K - PETMED EXPRESS INC (0001040130) (Filer)
4 - PETMED EXPRESS INC (0001040130) (Issuer)
4 - PETMED EXPRESS INC (0001040130) (Issuer)
4 - PETMED EXPRESS INC (0001040130) (Issuer)
Lake Street initiated coverage of PetMed Express with a rating of Buy and set a new price target of $20.00
Morgan Stanley reiterated coverage of PetMed Express with a rating of Underweight and set a new price target of $21.00 from $25.00 previously
Sidoti upgraded PetMed Express from Neutral to Buy and set a new price target of $32.00
DELRAY BEACH, Fla., July 23, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. ("PetMeds®") (NASDAQ:PETS) today announced that it partnered with the myBalto Foundation for its recent "Top of the Class" fundraising drive, resulting in nearly $45,000 in donations. myBalto is a leading platform dedicated to empowering veterinary hospitals to support pets with critical veterinary care. Its Foundation offers veterinary hospitals a free Angel Fund, eliminating the administrative burdens of setting up and managing a traditional charity, to help pet parents in need pay for emergency veterinarian costs. "PetMeds is proud to stand alongside organizations like myBalto Foundation that are expanding acces
DELRAY BEACH, Fla., April 11, 2025 (GLOBE NEWSWIRE) -- In celebration of National Pet Day, PetMed Express, Inc. (NASDAQ:PETS)—the original consumer pet healthcare company serving dogs, cats, and horses for nearly 30 years—will ring the Nasdaq Opening Bell this Friday, April 11, 2025. This momentous occasion honors the powerful bond between people and their pets and will feature adoptable rescue dogs from Bidawee, one of the nation's oldest no-kill animal welfare organizations. It's a tribute to the joy and unconditional love pets bring into our lives–and a reminder of how many still await families of their own. "Our pets are more than just animals; they are family," said Sandra Campo
Former pet industry executive with more than 20 years of experience across retail, pet, healthcare, and private equity Third independent director to join the Board since 2024 Longtime board member and former Chairman Dr. Gian Fulgoni will retire DELRAY BEACH, Fla., April 09, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., parent company of PetMeds and PetCareRx, (NASDAQ:PETS) (the "Company") today announced the appointment of Peter Batushansky to the Company's Board of Directors ("the Board"), effective April 09, 2025. Mr. Batushansky is currently a Partner at L2 Capital Partners and brings to the Board more than 20 years of experience across retail, pet, healthcare and private equity, i
DELRAY BEACH, Fla., June 16, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced preliminary fourth quarter and fiscal year 2025 results and filed Form 12b-25, Notification of Late Filing, with the Securities and Exchange Commission. The Company is unable to file its Annual Report on Form 10-K for the fiscal year ended March 31, 2025 within the prescribed time period without unreasonable effort or expense. The Company expects to file its Annual Report on Form 10-K with the Securities and Exchange Commission as soon as practicable, and no later than July 1, 2025, in accordance with Rule 12b-25. Preliminary Fourth Quarter
DELRAY BEACH, Fla., June 10, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced it is delaying the release of the Company's fourth quarter and fiscal year 2025 earnings release and subsequent conference call, which had been scheduled for June 10, 2025, because the Company requires additional time to complete the year-end audit process. The Company anticipates that it will issue the earnings release, hold the related conference call, and file its Annual Report on Form 10-K as soon as possible, but no later than June 16, 2025. About PetMed Express, Inc. Founded in 1996, PetMeds is a leader in pioneering the digital pet p
DELRAY BEACH, Fla., May 27, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) will hold a conference call on Tuesday, June 10, 2025 at 4:30pm Eastern Time to discuss its financial results for the fourth quarter and full fiscal year ended March 31, 2025. Financial results will be issued in a press release prior to the call. PETS management will host the conference call, followed by a question-and-answer period. Please call the conference telephone number 5-10 minutes prior to the start time. Date: Tuesday, June 10, 2025Time: 4:30pm Eastern Time (1:30pm Pacific Time)U.S. dial-in number: 877-407-0789International number: 201-689-8562We
SC 13G - PETMED EXPRESS INC (0001040130) (Subject)
SC 13G - PETMED EXPRESS INC (0001040130) (Subject)
SC 13G/A - PETMED EXPRESS INC (0001040130) (Subject)